WHO grants emergency use license to Bharat Biotech's COVAXIN

WHO approved COVAXIN, developed by Bharat Biotech for emergency use. The two dosages of vaccine are to be administered at a gap of four weeks. Now, according to the latest reports, the travellers who have taken both doses can also travel to USA from November 8th.  Watch the video to know more about the story. Stay connected for regular updates.